Global Targeted Metabolomics Market Growth (Status and Outlook) 2026-2032
Description
The global Targeted Metabolomics market size is predicted to grow from US$ 114 million in 2025 to US$ 250 million in 2032; it is expected to grow at a CAGR of 12.1% from 2026 to 2032.
Targeted metabolomics is a study in which defined metabolites in a sample are identified and quantitatively analyzed. Quantitation and semi-quantitation of defined metabolites are undertaken through the use of internal standard compounds. Targeted metabolomics has an advantage of high specificity and accuracy. Thus, this method has been widely used to analyze and compare multiple targeted metabolites under different physiological states, and is a critical analytical method for discovery of new biomarker in metabolic diseases and study of early diagnosis of diseases.
Targeted metabolomics is a rapidly growing and highly commercialized sub-segment of the metabolomics market. Its strong growth is primarily due to its superior suitability for absolute quantification, batch-to-batch standardization, clinical translation, and biomarker validation compared to non-targeted metabolomics. Demand is mainly driven by drug development, clinical research, precision medicine, nutrition, and chronic disease management. The core technologies are LC-MS/MS, particularly triple quadrupole platforms, with business models focusing on standardized panels, customized panels, and outsourced testing services. In terms of competition, upstream instrument manufacturers such as SCIEX, Thermo Fisher, Agilent, Waters, and Bruker dominate, while biocrates is a representative player in standardized reagent kits/solutions. Service providers include Metabolon, Creative Proteomics, Novogene, BGI, and Metware. Overall, targeted metabolomics represents a sub-segment with high technological barriers, strong service attributes, and a clear focus on clinical and industrial applications.
LPI (LP Information)' newest research report, the “Targeted Metabolomics Industry Forecast” looks at past sales and reviews total world Targeted Metabolomics sales in 2025, providing a comprehensive analysis by region and market sector of projected Targeted Metabolomics sales for 2026 through 2032. With Targeted Metabolomics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Metabolomics industry.
This Insight Report provides a comprehensive analysis of the global Targeted Metabolomics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Metabolomics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Metabolomics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Metabolomics and breaks down the forecast by Method, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Metabolomics.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Metabolomics market by product type, application, key players and key regions and countries.
Segmentation by Method:
NMR
GC-MS
LC-MS
HPLC-MS
Segmentation by Service Type:
Standardized Quantitative Services
Customized Service
Segmentation by Application:
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Creative Proteomics
Metabolon
Allumiqs
CD Genomics
Alfa Chemistry
Novelgene Technologies
Biognosys
Arome Science
Dalton Bioanalytics
Panome Bio
BGI
Metware
Applied Protein Technology
Shanghai Obio Technology
Beijing Biotech Pack Scientific
Abace Biotechnology
Please note: The report will take approximately 2 business days to prepare and deliver.
Targeted metabolomics is a study in which defined metabolites in a sample are identified and quantitatively analyzed. Quantitation and semi-quantitation of defined metabolites are undertaken through the use of internal standard compounds. Targeted metabolomics has an advantage of high specificity and accuracy. Thus, this method has been widely used to analyze and compare multiple targeted metabolites under different physiological states, and is a critical analytical method for discovery of new biomarker in metabolic diseases and study of early diagnosis of diseases.
Targeted metabolomics is a rapidly growing and highly commercialized sub-segment of the metabolomics market. Its strong growth is primarily due to its superior suitability for absolute quantification, batch-to-batch standardization, clinical translation, and biomarker validation compared to non-targeted metabolomics. Demand is mainly driven by drug development, clinical research, precision medicine, nutrition, and chronic disease management. The core technologies are LC-MS/MS, particularly triple quadrupole platforms, with business models focusing on standardized panels, customized panels, and outsourced testing services. In terms of competition, upstream instrument manufacturers such as SCIEX, Thermo Fisher, Agilent, Waters, and Bruker dominate, while biocrates is a representative player in standardized reagent kits/solutions. Service providers include Metabolon, Creative Proteomics, Novogene, BGI, and Metware. Overall, targeted metabolomics represents a sub-segment with high technological barriers, strong service attributes, and a clear focus on clinical and industrial applications.
LPI (LP Information)' newest research report, the “Targeted Metabolomics Industry Forecast” looks at past sales and reviews total world Targeted Metabolomics sales in 2025, providing a comprehensive analysis by region and market sector of projected Targeted Metabolomics sales for 2026 through 2032. With Targeted Metabolomics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Metabolomics industry.
This Insight Report provides a comprehensive analysis of the global Targeted Metabolomics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Metabolomics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Metabolomics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Metabolomics and breaks down the forecast by Method, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Metabolomics.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Metabolomics market by product type, application, key players and key regions and countries.
Segmentation by Method:
NMR
GC-MS
LC-MS
HPLC-MS
Segmentation by Service Type:
Standardized Quantitative Services
Customized Service
Segmentation by Application:
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Creative Proteomics
Metabolon
Allumiqs
CD Genomics
Alfa Chemistry
Novelgene Technologies
Biognosys
Arome Science
Dalton Bioanalytics
Panome Bio
BGI
Metware
Applied Protein Technology
Shanghai Obio Technology
Beijing Biotech Pack Scientific
Abace Biotechnology
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
126 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Targeted Metabolomics Market Size by Player
- 4 Targeted Metabolomics by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Targeted Metabolomics Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
